Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive genomic characterization of translocation renal cell carcinoma.

ABSTRACT: Comprehensive genomic characterization of translocation renal cell carcinoma.

PROVIDER: PRJNA865000 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Comprehensive genomic characterization of translocation renal cell carcinoma.

Project description:Comprehensive genomic characterization of translocation renal cell carcinoma.

| PRJNA865001 | ENA

Proteogenomic Characterization of MiT Family Translocation Renal Cell Carcinoma

Project description:Comprehensive proteogenomic analysis of Microphthalmia Transcription Factor (MiT) family translocation renal cell carcinoma (tRCC) tumor and normal adjacent tissues was performed to elucidate the molecular landscape of these tumors.

2022-07-20 | PXD035377 |

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

Project description:Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

| PRJNA780561 | ENA

TFE3 Xp11.2 translocation renal cell carcinoma mouse model

Project description:TFE3 Xp11.2 translocation renal cell carcinoma mouse model

| PRJNA533790 | ENA

TFE3 Xp11.2 translocation renal cell carcinoma mouse model

Project description:Renal Cell Carcinoma (RCC) associated with Xp11.2 translocation (TFE3-RCC) has been recently defined as a distinct subset of RCC. The Xp11 translocations involve the TFE3 transcription factor and produce chimeric TFE3 proteins retaining the basic helix-loop-helix leucine zipper structure for dimerization. To facilitate the development of molecular-based diagnostic tools and targeted therapies for TFE3-RCC, we generated a translocation RCC mouse model and performed DNA microarray analysis.

2019-04-20 | GSE130072 | GEO

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

Project description:Translocation renal cell carcinoma (tRCC) is a poorly-characterized subtype of kidney cancer driven by MiT/TFE gene fusions. Here, we define the landmarks of tRCC through an integrative analysis of 152 patients with tRCC identified across multiple genomic, clinical trial, and retrospective cohorts. Most tRCCs harbor few somatic alterations apart from MiT/TFE fusions and homozygous deletions at chromosome 9p21.3 (19.2% of cases). Transcriptionally, tRCCs display a heightened NRF2-driven antioxidant response that is associated with resistance to many targeted therapies. Consistently, we find that outcomes for patients with tRCC treated with vascular endothelial growth factor receptor inhibitors (VEGFR-TKI) are worse than those treated with immune checkpoint inhibition (ICI). Multiparametric immunofluorescence confirmed the presence of CD8+ tumor-infiltrating T cells compatible with a clinical benefit from ICI and revealed an exhaustion immunophenotype distinct from that of clear cell RCC. Our findings comprehensively define the clinical and molecular features of tRCC and may inspire new therapeutic hypotheses.

2021-11-22 | GSE188885 | GEO

Genomic characterization of Chinese clear cell renal cell carcinoma

Project description:Large-scale initiatives like The Cancer Genome Atlas (TCGA) performed omics studies on hundreds of kidney cancer patients, but predominantly on Caucasians. We now investigated genomics of Chinese clear cell renal cell carcinoma (ccRCC) patients.

2020-02-22 | GSE126964 | GEO

Genomic characterization of Chinese clear cell renal cell carcinoma

Project description:Genomic characterization of Chinese clear cell renal cell carcinoma

| PRJNA523858 | ENA

Next generation sequencing of TFE3-translocation renal cell carcinoma and adjacent normal tissue transcriptomes

Project description:Next generation sequencing of TFE3-translocation renal cell carcinoma and adjacent normal tissue transcriptomes

| PRJNA704974 | ENA

Renal papillary cell carcinoma

Project description:Renal papillary cell carcinoma

| PRJNA749556 | ENA